BIOTECH & PHARMA

    Biotech and pharma stocks listed on the ASX.

    MGC Pharmaceuticals ASX MXC nutraceuticals CBD Chinese health products YuShop Global

    MGC Pharmaceuticals enters Chinese market with CBD products

    Next Science ASX NXS IPO chairman George Savvides CEO Judith Mitchell CFO Jacqueline Butler

    Next Science gears up for ASX debut with product arsenal against antibiotic resistant bacteria

    Osprey Medical ASX OSP DyeVert sales increase 2019

    Osprey Medical posts strong first quarter sales for DyeVert products

    Noxopharm ASX NOX Veyonda chemotherapy enhancement cancer study

    Noxopharm claims idronoxil drug could boost effect of chemo and radiation in fighting cancer

    Paradigm Biopharma ASX PAR phase 2b secondary endpoints pentosan polysulfate sodium

    Paradigm Biopharma’s knee osteoarthritis trial meets secondary endpoints, launches capital raise

    Genetic Technologies ASX GTG Translational Genomics Research Institute TGen partners US research centre commercialise polygenic risk tests

    Genetic Technologies partners with US research centre to commercialise polygenic risk tests

    Imugene ASX IMU cancer vaccine tumour oncology

    Imugene unveils swathe of positive data on cancer vaccine trials

    Impression Healthcare Cannvalate ASX IHL medical cannabis trials

    Impression Healthcare aims for competitive edge over ‘cure-all’ suppliers with unique medical cannabis trials

    Genetic Technologies ASX GTG China market

    Genetic Technologies taps China’s market with locally-based operation

    Bod Australia ASX BDA medicinal cannabis product clinical trial Phase 1

    Clinical trial highlights tolerability of Bod Australia’s medicinal cannabis product

    Recce Pharmaceuticals ASX RCE synthetic antibiotic superbug US patent

    Recce Pharmaceuticals locks-in US patent for synthetic antibiotic to target growing superbug problem

    PharmAust ASX PAA Monepantel tablets Phase 1 dogs

    PharmAust reports positive results from phase I anti-cancer tablet trial on dogs

    Load more
    Small Caps ASX Australian stock market
    Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

    Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.
    Copyright 2019 Small Caps. All rights reserved.